We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > relief

News List

NeuroRx Announces ZYESAMI Trial Met Primary Endpoint americanpharmaceuticalreview
March 30, 2021
NeuroRx reports 60-day results of the Phase 2b/3 trial of intravenously-administered ZYESAMI™ (aviptadil acetate) for the treatment of respiratory failure in critically-ill patients with COVID-19, which is being developed in collaboration with ...
SignPath, Relief explore drugs for Covid-19-related ARDS pharmaceutical-technology
March 19, 2020
SignPath Pharma has begun efforts to develop Lipocurc, an intravenous liposomal curcumin formulation, to treat acute respiratory distress syndrome (ARDS) caused by Covid-19.
A 5-Minute Recipe for Stress Relief drugs
June 05, 2019
A 5-Minute Recipe for Stress Relief.